UNICREDIT BANK GMBH | Market Closed - Borsa Italiana 16:44:59 30/05/2024 BST | ||
| 67.9 EUR | -3.50% |
|
| Current month | +16.63% | ||
| 1 month | +16.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CUREVAC N.V.
Latest news about CUREVAC N.V.
More news
| Date | Price | Change |
|---|---|---|
| 30/05/24 | 67.9 | -3.50% |
| 29/05/24 | 70.36 | +5.31% |
| 28/05/24 | 66.81 | -3.30% |
| 27/05/24 | 69.09 | -1.86% |
| 24/05/24 | 70.4 | -0.56% |
Real-time Borsa Italiana
Last update May 30, 2024 at 04:44 pm
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | CUREVAC N.V. |
| Issuer | 
UniCredit
|
| UC24DG | |
| ISIN | DE000HC24DG7 |
| Date issued | 22/11/2022 |
| Strike | 7.95 $ |
| Maturity | 11/12/2025 (560 Days) |
| Parity | 0.08 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 107.2 € |
|---|---|
| Lowest since issue | 55.2 € |
| Spread | 1.36 € |
| Spread % | 1.99% |
Company Profile
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve peopleâs lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Sector
-
Consensus: CureVac N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3.477
EUR
Average target price
8.933
EUR
Spread / Average Target
+156.94%
- Stock Market
- Certificates
- UC24DG Certificat
